Trial Profile
A Phase 3, Randomized, Double-blind, Double-dummy, Comparative Study of LX-P in Patients with Chronic Low Back Pain (BRAND)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Loxoprofen (Primary) ; Loxoprofen
- Indications Back pain
- Focus Therapeutic Use
- Acronyms BRAND
- Sponsors Lead Chemical
- 08 Jun 2016 New trial record